Article

Carotid artery stenting: a 2009 update.

Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, Groningen, The Netherlands.
Current opinion in cardiology (Impact Factor: 2.66). 08/2009; 24(6):528-31. DOI: 10.1097/HCO.0b013e328330c302
Source: PubMed

ABSTRACT Carotid endarterectomy (CEA) is still considered the gold standard in the treatment of patients with significant carotid stenosis and has proven its value over the past decades. Endovascular techniques have evolved, and carotid artery stenting (CAS) is challenging CEA to become the better treatment. Various trends were noted throughout the past decade with shifts against and pro CAS. The aim of this review is to describe the most important findings related to CAS, published in the last 1.5 years, in order to present its current status.
A total of 12 randomized trials have been initiated at this moment. The long-term results of both the Stent-Protected Angioplasty versus Carotid Endarterectomy and Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis trials were published last year. Last month, primary safety data from the International Carotid Stenting Study trial were also presented. All these three trials failed to show superiority of CAS. Results favored CEA mainly because of periprocedural complications with CAS.
It is anticipated that whenever eligible for CEA, patients should be scheduled to undergo surgery, reserving CAS for high-risk patients and patients with anatomical restrictions. Most likely, evolving best medical treatment, timely intervention and analysis of plaque composition will have an important influence on the future treatment of carotid artery stenosis, regardless of the treatment option chosen.

1 Bookmark
 · 
211 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The probability of atherosclerotic plaque rupture and its thrombotic sequelae are thought to be increased at sites of macrophage accumulation. Folate receptor β (FR-β) is present on activated macrophages but not on quiescent macrophages or other immune cells. By conjugating the ligand folate with a fluorescent contrast agent, fluorescein isothiocyanate (FITC), we aimed to explore the potential role of FR-β fluorescence imaging in the distinction of vulnerable sites from more stable regions. Carotid specimens were taken from 20 patients and incubated with folate-FITC for 30 min. Ex vivo fluorescence imaging was performed to determine the exact location of folate-FITC uptake. Sections displaying regions of high uptake (determined as hot spots) were compared with sections showing low uptake (cold spots) through immunohistochemistry and real-time quantitative reverse-transcription polymerase chain reaction for FR-β. Hot spots showed significantly higher folate-FITC uptake than cold spots (P < 0.001). Hot spots tended to contain more macrophages and areas of hypoxia than cold spots. A positive correlation between messenger RNA levels of CD68 (marker for macrophages), FR-β (r = 0.53, P = 0.045), and hypoxia-inducible factor-1α expression (marker for intraplaque hypoxia; r = 0.55, P = 0.034) was found. Compared with areas with low folate-FITC uptake, areas of high folate-FITC uptake within human atherosclerotic plaques had an increased number of activated macrophages and higher areas of hypoxia. These characteristics of vulnerability imply that molecular imaging of FR-β through folate conjugates might be a good indicator for plaque vulnerability in future noninvasive imaging studies.
    Journal of Nuclear Medicine 08/2012; 53(8):1222-9. · 5.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Continuous improvement in carotid artery stenting (CAS) outcomes, especially for periprocedural death and stroke in high-surgical-risk patients, have been seen in recent randomized trials of CAS versus carotid endarterectomy and CAS registries. However, these studies use stringent inclusion/exclusion criteria for patient, institution, and physician selection. The Carotid Stenting Boston Scientific Surveillance Program (CABANA) study was initiated to evaluate periprocedural outcomes with modern versions of the Carotid Wallstent and FilterWire EZ System for operators with a wide range of clinical specialties, CAS experience and training levels, in patients with a broad range of high-surgical-risk conditions and lesion types. This prospective, single-arm study enrolled 1,097 subjects with 1,098 carotid artery lesions at 99 study centers. Investigators were grouped into one of three tiers according to whether they had a high, medium, or low level of previous CAS experience and were also categorized by their CAS-credential-based training requirements for the CABANA study. Follow-up at 30 days includes clinical evaluation and independent neurological and NIH stroke scale assessments. The primary endpoint rate of 30-day composite stroke, death, and MI, as well as the rates of these individual events, will be evaluated across the overall study, by physician experience tier, and by physician training tier. The evaluation of periprocedural CAS safety in a real-world environment with modern devices in high-surgical-risk patients treated by physicians with a broad range of training and experience will better inform treatment decisions in the future.
    Catheterization and Cardiovascular Interventions 07/2011; 79(1):167-73. · 2.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plaque rupture or erosion represents a major cause of stroke and the acute coronary syndrome. Information on plaque morphology and composition is essential to identify patients at increased risk for acute cardio- and cerebrovascular events, and may play a key role in individualizing therapeutic strategies and monitoring the effect of interventions. The rapidly emerging field of MR and targeted molecular MRI allows to qualitatively and quantitatively characterize plaque features. We aimed to review the literature regarding the current most promising advanced techniques to image vulnerable atherosclerotic plaques.
    Interventional neurology. 09/2013; 1(3-4):124-31.

Full-text

Download
0 Downloads
Available from